These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12243815)

  • 1. Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trial.
    Miller RC; Sargent DJ; Martenson JA; Macdonald JS; Haller D; Mayer RJ; Gunderson LL; Rich TA; Cha SS; O'Connell MJ
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):409-13. PubMed ID: 12243815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
    J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma.
    Miller RC; Martenson JA; Sargent DJ; Kahn MJ; Krook JE
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):593-8. PubMed ID: 9635707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response.
    Mohiuddin M; Regine WF; John WJ; Hagihara PF; McGrath PC; Kenady DE; Marks G
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):883-8. PubMed ID: 10705009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II study of preoperative oxaliplatin, fluorouracil, and external-beam radiation therapy in patients with locally advanced rectal cancer: Cancer and Leukemia Group B 89901.
    ; Ryan DP; Niedzwiecki D; Hollis D; Mediema BE; Wadler S; Tepper JE; Goldberg RM; Mayer RJ
    J Clin Oncol; 2006 Jun; 24(16):2557-62. PubMed ID: 16636336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies.
    Valentini V; Coco C; Cellini N; Picciocchi A; Fares MC; Rosetto ME; Mantini G; Morganti AG; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):371-83. PubMed ID: 11567811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
    Thrall MM; Wood P; King V; Rivera W; Hrushesky W
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisole in patients with TNM stage II-III resectable rectal cancer.
    Cafiero F; Gipponi M; Peressini A; Bertoglio S; Lionetto R
    J Surg Oncol; 2000 Oct; 75(2):80-8. PubMed ID: 11064385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy.
    Martenson JA; Shanahan TG; O'Connell MJ; Cobau CD; Schroeder G; Burch PA; Levitt R; Rowland KM
    Cancer; 1999 Aug; 86(4):710-4. PubMed ID: 10440700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
    Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
    Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report.
    Cafiero F; Gipponi M; Lionetto R;
    J Surg Oncol; 2003 Jul; 83(3):140-6. PubMed ID: 12827681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
    Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
    J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer.
    Navarro M; Dotor E; Rivera F; Sánchez-Rovira P; Vega-Villegas ME; Cervantes A; García JL; Gallén M; Aranda E
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):201-5. PubMed ID: 16814947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
    Minsky BD; Cohen AM; Kemeny N; Enker WE; Kelsen DP; Reichman B; Saltz L; Sigurdson ER; Frankel J
    J Clin Oncol; 1992 Jan; 10(1):79-84. PubMed ID: 1727928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation.
    Valentini V; Coco C; Cellini N; Picciocchi A; Rosetto ME; Mantini G; Marmiroli L; Barbaro B; Cogliandolo S; Nuzzo G; Tedesco M; Ambesi-Impiombato F; Cosimelli M; Rotman M
    Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1175-84. PubMed ID: 10613310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy using CPT-11, leucovorin plus bolus 5-fluorouracil and radiotherapy in patients with rectal cancer. A feasibility study.
    Kalofonos HP; Kardamakis D; Bamias A; Skarlos D; Papakostas P; Bafaloukos D; Sakantamis A; Pavlidis N; Fountzilas G
    Anticancer Res; 2003; 23(2C):1687-91. PubMed ID: 12820441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucovorin and fluorouracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer.
    Tsavaris N; Gennatas K; Kosmas C; Skopelitis HM; Gouveris P; Dimitrakopoulos A; Zacharakis M; Kouraklis G; Vasiliou J; Felekouras E; Voros D; Zografos G; Balafouta M; Paraskevaidis M; Safioleas M; Fotiadis K; Papastratis G; Karatzas G; Papalambros E
    Oncol Rep; 2004 Oct; 12(4):927-32. PubMed ID: 15375524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant modified FOLFOX-4 in patients with stage III rectum adenocarcinoma.
    Cihan Ş; Uncu D; Babacan NA; Özdemir N; Odabaş H; Aksoy S; Öksüzoğlu B; Zengin N
    Asian Pac J Cancer Prev; 2011; 12(4):967-70. PubMed ID: 21790235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.